SBI Funds Management Limited (New IPO): GMP, Price, Review, Profit

SBI Funds Management Limited

SBI Funds Management Limited has filed its DRHP with SEBI for a proposed IPO featuring entirely as an Offer for Sale (OFS) of 203,709,239 Equity Shares.

Rayzon Solar Limited (New IPO): GMP, Price, Review, Profit

Rayzon Solar Limited

Rayzon Solar Limited has filed its DRHP with SEBI for a proposed IPO featuring entirely as a Fresh Issue of ₹ 1500 Crore and no Offer for Sale (OFS).

Safex Chemicals (India) Limited (NEW IPO): GMP, Price, Review, Profit

Safex Chemicals (India) Limited

Safex Chemicals (India) Limited has filed its DRHP with SEBI for a proposed IPO featuring a Fresh Issue of ₹ 450 Crore and Offer for Sale (OFS) of 35,734,818 Equity Shares.

Parijat Industries India (New IPO): GMP, Profit, Price & expert review

Parijat Industries India

Parijat Industries (India) Limited is a leading fully integrated agrochemical company headquartered in New Delhi. It specializes in the research, development, and manufacturing of high-quality crop protection solutions, including insecticides, fungicides, herbicides, and plant nutrition products.
Parijat Industries has filed DRHP with SEBI for a proposed IPO consisting as Fresh Issue of Up to ₹ 160 Cr & Offer for Sale (OFS) of 20,370,680 Equity Shares.

Dhariwal Buildtech Limited IPO: GMP today, Price, Review, Detail

Dhariwal Buildtech Limited

Dhariwal Buildtech Limited is a Haryana‑based infrastructure construction company specialising in engineering, procurement and construction (EPC) of roads, highways, state highways, rural roads, bridges, tunnels, railway over bridges, irrigation, and other civil infrastructure projects across India.
It has filed DRHP with SEBI for IPO with an issue size of ₹950 Crore consisting completely as Fresh Issue of ₹950 Crore & no Offer for Sale (OFS) .

Virupaksha Organics Limited IPO: GMP today, Price, Review, Detail

Virupaksha Organics Limited

Virupaksha Organics Limited is an R&D-driven Indian pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients (APIs), key starting materials (KSMs) and intermediates, and also provides contract development & manufacturing services to global pharma companies.
Virupaksha Organics has filed DRHP with SEBI for IPO having an issue size of ₹ 740 Cr, completely as Fresh Issue of ₹ 740 crore and no Offer for Sale (OFS).